CL2014002401A1 - Composicion de accion prolongada que incluye un agente bioactivo, un portador no acuoso, aceite de ricino y al menos una amida ciclica; metodo de preparacion; uso para prevenir o tratar una infeccion parasitaria en un animal. - Google Patents

Composicion de accion prolongada que incluye un agente bioactivo, un portador no acuoso, aceite de ricino y al menos una amida ciclica; metodo de preparacion; uso para prevenir o tratar una infeccion parasitaria en un animal.

Info

Publication number: CL2014002401A1
Authority: CL; Chile
Prior art keywords: treat; animal; preparation; prevent; castor oil
Prior art date: 2012-03-13

Application number

CL2014002401A

Other languages

English (en)

Inventor

Nanjan Karthigeyan

Al Alawi Fadil

Original Assignee

Bayer New Zealand Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2012-03-13

Filing date

2014-09-11

Publication date

2015-04-17

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49161532&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014002401(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-09-11 Application filed by Bayer New Zealand Ltd filed Critical Bayer New Zealand Ltd

2015-04-17 Publication of CL2014002401A1 publication Critical patent/CL2014002401A1/es

Links

208000030852 Parasitic disease Diseases 0.000 title 1
239000008365 aqueous carrier Substances 0.000 title 1
239000012867 bioactive agent Substances 0.000 title 1
239000004359 castor oil Substances 0.000 title 1
235000019438 castor oil Nutrition 0.000 title 1
150000003950 cyclic amides Chemical class 0.000 title 1
ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 title 1
238000002360 preparation method Methods 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Tropical Medicine & Parasitology (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Plant Substances (AREA)

CL2014002401A 2012-03-13 2014-09-11 Composicion de accion prolongada que incluye un agente bioactivo, un portador no acuoso, aceite de ricino y al menos una amida ciclica; metodo de preparacion; uso para prevenir o tratar una infeccion parasitaria en un animal. CL2014002401A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
NZ59875712		2012-03-13

Publications (1)

Publication Number	Publication Date
CL2014002401A1 true CL2014002401A1 (es)	2015-04-17

Family

ID=49161532

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL2014002401A CL2014002401A1 (es)	2012-03-13	2014-09-11	Composicion de accion prolongada que incluye un agente bioactivo, un portador no acuoso, aceite de ricino y al menos una amida ciclica; metodo de preparacion; uso para prevenir o tratar una infeccion parasitaria en un animal.

Country Status (20)

Country	Link
US (1)	US9616044B2 (es)
EP (1)	EP2825154A4 (es)
JP (1)	JP6273252B2 (es)
KR (1)	KR20140136005A (es)
CN (1)	CN104168886A (es)
AU (1)	AU2013201479C1 (es)
CA (1)	CA2867079A1 (es)
CL (1)	CL2014002401A1 (es)
CO (1)	CO7071132A2 (es)
CR (1)	CR20140423A (es)
DO (1)	DOP2014000207A (es)
IL (1)	IL234597A0 (es)
MX (1)	MX354966B (es)
NI (1)	NI201400106A (es)
PE (1)	PE20142279A1 (es)
PH (1)	PH12014502016A1 (es)
RU (1)	RU2014141088A (es)
SV (1)	SV2014004804A (es)
WO (1)	WO2013137748A1 (es)
ZA (1)	ZA201406753B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITUB20153652A1 (it)	2015-09-16	2017-03-16	Fatro Spa	Microsfere contenenti lattoni macrociclici antielminitici

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5169846A (en) *	1989-10-12	1992-12-08	Crooks Michael J	Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators
DK0535734T3 (da) *	1991-09-30	1999-08-09	Merck & Co Inc	Langtidsvirkende injicerbare formuleringer indeholdende hydrogeneret castorolie
DE19520275A1 (de)	1995-06-02	1996-12-05	Bayer Ag	Endoparasitizide Mittel
CA2233016C (en)	1995-09-25	2007-07-17	Ashmont Holdings Limited	Anthelmintic macrocyclic lactone compositions
DE19613972A1 (de) *	1996-04-09	1997-10-16	Bayer Ag	Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
DE19638045A1 (de)	1996-09-18	1998-03-19	Bayer Ag	Injektionsformulierungen von Avermectinen und Milbemycinen
US6998131B2 (en) *	1996-09-19	2006-02-14	Merial Limited	Spot-on formulations for combating parasites
GB9815801D0 (en) *	1998-07-21	1998-09-16	Merck & Co Inc	Liquid polymeric compositions for controlled released bioactive substances
CN1130990C (zh)	1999-11-02	2003-12-17	王毅远	一种纯天然方便食品及其制造方法
US6340672B1 (en)	2000-02-16	2002-01-22	Phoenix Scientific, Inc.	Parasiticidal formulation and a method of making this formulation
AU781682B2 (en)	2000-03-20	2005-06-09	Zoetis Services Llc	Sustained-release compositions for parenteral administration
CN1383821A (zh)	2001-03-16	2002-12-11	王玉万	一种含丙硫苯咪唑亚砜或其盐类的兽用注射剂
AU2002100152A4 (en) *	2002-02-28	2002-04-11	Jurox Pty Ltd	Parasiticide composition
US7001889B2 (en) *	2002-06-21	2006-02-21	Merial Limited	Anthelmintic oral homogeneous veterinary pastes
US6653288B1 (en) *	2002-09-30	2003-11-25	Virbac S.A.	Injectable anthelmintic compositions and methods for using same
CN1490009A (zh) *	2002-10-17	2004-04-21	王玉万	含抗球虫药物的缓释注射剂
US20060257440A1 (en) *	2003-05-19	2006-11-16	Makoto Asai	Insecticidal composition
NZ535644A (en)	2003-07-25	2007-05-31	Ashmont Holdings Ltd	Anthelmintic formulations
CN1293921C (zh)	2003-08-18	2007-01-10	王玉万	含乙基纤维素和脂肪酸酯类的长效注射剂
TR200601608T1 (tr)	2003-10-17	2006-12-21	Akzo Nobel N.V	Bir avermektin kombinasyonu içeren uzun süre etkili bileşimler.
AU2005100403B4 (en) *	2005-05-13	2005-09-01	Jurox Pty Ltd	Parasiticide Composition
BRPI0800259A2 (pt) *	2008-02-27	2011-05-31	Noxon Do Brasil Quimica E Farmaceutica Ltda	formulações veterinárias compreendendo lactonas macrocìclicas e minerais, seus usos na preparação de produtos veterinários e métodos de ganho de produtividade e tratamento e/ou profilaxia de doenças causadas por agentes biológicos nocivos à saúde animal
NZ590141A (en)	2008-06-24	2012-05-25	Merial Ltd	Anthelminthic formulations including castor oil and another vegetable oil
MX2009001235A (es) *	2008-09-19	2010-04-29	Agrovet Market S A	Composicion y uso de un gel oral endoparasiticida bioadhesivo de larga accion a base de doramectina.
DK2396006T3 (da) *	2009-02-16	2013-02-11	Ah Usa 42 Llc	Doramectinformulering med høj dosis
CN101703776B (zh) *	2009-09-28	2012-07-11	洛阳惠中兽药有限公司	一种抗感染剂长效注射液的制备方法
BRPI1001224A2 (pt)	2010-04-07	2011-03-15	Clarion Biociencias Ltda	processo de fabricação de formulação injetável a base de fluazuron associado a avermectinas para o controle e prevenção de endo e ectoparasitas em animais domésticos
WO2012089623A1 (en) *	2010-12-27	2012-07-05	Intervet International B.V.	Topical localized isoxazoline formulation comprising glycofurol

2013
- 2013-03-13 CN CN201380014128.7A patent/CN104168886A/zh active Pending
- 2013-03-13 RU RU2014141088A patent/RU2014141088A/ru unknown
- 2013-03-13 PE PE2014001416A patent/PE20142279A1/es not_active Application Discontinuation
- 2013-03-13 WO PCT/NZ2013/000036 patent/WO2013137748A1/en not_active Ceased
- 2013-03-13 KR KR1020147026646A patent/KR20140136005A/ko not_active Withdrawn
- 2013-03-13 US US14/384,308 patent/US9616044B2/en not_active Expired - Fee Related
- 2013-03-13 CA CA2867079A patent/CA2867079A1/en not_active Abandoned
- 2013-03-13 EP EP13760308.0A patent/EP2825154A4/en not_active Withdrawn
- 2013-03-13 JP JP2015500382A patent/JP6273252B2/ja not_active Expired - Fee Related
- 2013-03-13 MX MX2014010957A patent/MX354966B/es active IP Right Grant
- 2013-03-13 AU AU2013201479A patent/AU2013201479C1/en active Active
2014
- 2014-09-09 PH PH12014502016A patent/PH12014502016A1/en unknown
- 2014-09-10 SV SV2014004804A patent/SV2014004804A/es unknown
- 2014-09-11 IL IL234597A patent/IL234597A0/en unknown
- 2014-09-11 DO DO2014000207A patent/DOP2014000207A/es unknown
- 2014-09-11 NI NI201400106A patent/NI201400106A/es unknown
- 2014-09-11 CL CL2014002401A patent/CL2014002401A1/es unknown
- 2014-09-15 ZA ZA2014/06753A patent/ZA201406753B/en unknown
- 2014-09-15 CO CO14203983A patent/CO7071132A2/es unknown
- 2014-09-16 CR CR20140423A patent/CR20140423A/es unknown

Also Published As

Publication number	Publication date
US9616044B2 (en)	2017-04-11
CR20140423A (es)	2014-10-20
NI201400106A (es)	2015-01-14
US20150038565A1 (en)	2015-02-05
JP6273252B2 (ja)	2018-01-31
ZA201406753B (en)	2015-12-23
AU2013201479A1 (en)	2013-10-03
KR20140136005A (ko)	2014-11-27
WO2013137748A1 (en)	2013-09-19
DOP2014000207A (es)	2014-11-30
JP2015509978A (ja)	2015-04-02
CN104168886A (zh)	2014-11-26
EP2825154A4 (en)	2015-11-11
EP2825154A1 (en)	2015-01-21
AU2013201479B2 (en)	2015-07-02
AU2013201479C1 (en)	2017-11-09
MX354966B (es)	2018-03-27
PE20142279A1 (es)	2015-01-25
CO7071132A2 (es)	2014-09-30
MX2014010957A (es)	2014-10-13
SV2014004804A (es)	2017-04-20
IL234597A0 (en)	2014-11-30
CA2867079A1 (en)	2013-09-19
RU2014141088A (ru)	2016-05-10
PH12014502016B1 (en)	2014-11-24
PH12014502016A1 (en)	2014-11-24

Publication	Publication Date	Title
CL2014000601A1 (es)	2014-10-10	Composición tópica veterinaria que comprende al menos un agente activo derivado de isoxazolina; y uso de la composición para el tratamiento o prevención de una infestación o infección por parásitos en un animal.
CL2014003509A1 (es)	2015-04-17	Composición veterinaria masticable blanda que comprende como agente activo un compuesto derivado de isoxazolina; y su uso para el tratamiento y/o prevención de una infestación y/o infección por parásitos en un animal (div. sol. n°2087-14).
BR112015002541A2 (pt)	2017-12-05	composto, composição farmacêutica, uso de um composto, e, método para tratamento de hcv em um paciente.
BR112014023937A2 (pt)	2018-04-17	composição farmacêutica, agente farmacêutico de combinação e método de tratamento
AR092330A1 (es)	2015-04-15	Composiciones, metodos de absorcion transmucosa y metodo de tratamiento
CR20140365A (es)	2014-12-03	Compuestos de carbamato y preparación y uso de los mismos
CL2015003801A1 (es)	2016-07-15	Formulaciones de anticuerpos y metodos
MX370664B (es)	2019-12-19	Inhibidores de la proteína regulada por glucosa 94 (gpr94) selectivos y usos de los mismos.
BR112014027544A2 (pt)	2018-04-17	composição cosmética, processo cosmético e uso cosmético.
CL2014002348A1 (es)	2015-01-23	Compuestos derivados de fenicol; composicion farmaceutica que los comprende; y su uso para controlar o tratar infecciones bacterianas en ganado.
PH12015501888A1 (en)	2015-12-07	Novel bacteriophage and antibacterial composition comprising the same
CR20140579A (es)	2015-03-13	Composicion herbicida que tiene actividad herbicida mejorada
NI201500118A (es)	2015-10-19	Imidazopiridazinas sustituidas
EA201200484A1 (ru)	2012-12-28	Фармацевтическая композиция с действующими веществами - метформином и ситаглиптином или вилдаглиптином
CL2015003273A1 (es)	2016-05-27	Método para estabilizar suspensiones de glóbulos rojos que encapsulan un ingrediente activo, y suspensiones obtenidas
AR091739A1 (es)	2015-02-25	Composiciones y metodos para reducir el riesgo cardiometabolico
BR112015014885A2 (pt)	2017-07-11	combinação de agentes ativos, composição cosmética e/ou dermatológica e processo para a preparação de uma composição de agentes ativos.
MX379984B (es)	2025-03-11	Reducción de la sensación de picazón en la piel.
BR112014026873A2 (pt)	2017-06-27	método cosmético, composição cosmética e uso.
MX365321B (es)	2019-05-29	Métodos para el tratamiento de neutropenia mediante agonistas retinoides.
MX2014011855A (es)	2016-09-09	Sistemas y metodos para tratar una respuesta farmacodinamica adversa inducida por opioides.
CR20160235A (es)	2016-07-20	Tienopirimidinas como inhibidores mknk1 y mknk2
PT2900251T (pt)	2017-01-18	Novos extratos de cynara scolymus, coffea spp. e olea europaea para o tratamento da síndrome metabólica
CL2015001748A1 (es)	2015-11-13	Formulaciones antiparasitarias transdermicas
AR098742A1 (es)	2016-06-08	Composición alimenticia realzadora de la palatabilidad para alimento para mascotas y método de preparación